Health-care companies rose as traders rotated back into sectors that are less sensitive to shifts in inflation and oil prices.
Health-care companies rose as traders rotated back into sectors that are less sensitive to shifts in inflation and oil prices.
Sionna Therapeutics plunged more than 90% after the biotech company said it was shelving a highly anticipated cystic fibrosis drug candidate because it failed to meet the key endpoint in a proof-of-concept trial.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
August 10, 2026 17:34 ET (21:34 GMT)
Health-care companies fell as traders rotated out of defensive sectors and back into the tech sector.
Health-care companies fell as traders continued to rotate out of a sector beset by growth and regulatory concerns.
Health-care companies slipped as traders rotated into sectors with more to gain from a decline in oil prices.
Health-care companies rose as traders continued to rotate out of high-momentum semiconductor and artificial-intelligence stocks…
Health-care companies rose sharply in an abrupt sector rotation.
Health-care companies rose as traders rotated into some lagging sectors.
